Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.63 |
| ▸ | DGKA | P23743 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | RAD52 | P43351 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | MGLL | Q99685 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27468688 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL27563351 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL27289034 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL8864049 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL27913957 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL27875882 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL4083624 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL27500017 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL28264985 | 0.98 | NAAA (0.67) | NAAADGKAHTR2CFAAHRAD52 | |
| SCHEMBL446637 | 0.93 | DGKA (0.59) | NAAADGKAHTR2CFAAHRAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113101937-A | Doped mixed-valence copper catalyst and preparation method and application thereof | 厦门大学 | 2021-07-13 | — | — | CN | claimed |
| CN-119897121-A | Fullerene modified copper-containing mixed metal silica catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-116351425-B | Supported binary alloy catalyst and method for preparing 1, 3-propylene glycol by catalyzing hydrogenation of 3-hydroxy propionate | 厦门大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-116351425-A | Supported binary alloy catalyst and method for preparing 1, 3-propylene glycol by catalyzing hydrogenation of 3-hydroxy propionate | 厦门大学 | 2023-06-30 | — | — | CN | disclosed |
| CN-114345339-B | Supported binary metal catalyst, preparation method and application thereof | 厦门大学 | 2023-02-21 | — | — | CN | disclosed |
| CN-114345339-A | Supported binary metal catalyst, preparation method and application thereof | 厦门大学 | 2022-04-15 | — | — | CN | disclosed |
| CN-113101937-A | Doped mixed-valence copper catalyst and preparation method and application thereof | 厦门大学 | 2021-07-13 | — | — | CN | disclosed |
| US-20200392058-A1 | METHOD FOR PREPARING 1,3-PROPANEDIOL BY COUPLING ETHYLENE OXIDE WITH SYNGAS | XIAMEN UNIVERSITY (CN) | 2020-12-17 | — | — | US | disclosed |
| CN-110105169-B | Method for preparing 1, 3-propylene glycol by coupling ethylene oxide with synthesis gas | 厦门大学 | 2020-10-27 | — | — | CN | disclosed |
| CN-104860682-B | Cofired ceramic heating member preparation technology | 东莞市国研电热材料有限公司 | 2017-02-15 | — | — | CN | disclosed |
| EP-0382185-B1 | Carbostyril derivatives | OTSUKA PHARMA CO LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| WO-1994004525-A1 | BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-03-03 | — | — | WO | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| US-5244898-A | Vasopressin antagonist | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0514667-A1 | Benzazepin derivatives as vasopressin antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-25 | — | — | EP | disclosed |
| EP-0450097-A1 | BENZOHETEROCYCLIC COMPOUNDS. | OTSUKA PHARMA CO LTD (JP) | 1991-10-09 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |
| EP-0382185-A2 | Carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4005189-A | Process of suppressing odors employing deodorants containing esters of aliphatic hydroxycarboxylic acids | HENKEL & CIE G.M.B.H. (DT) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392058-A1 | METHOD FOR PREPARING 1,3-PROPANEDIOL BY COUPLING ETHYLENE OXIDE WITH SYNGAS | HPD, HSD17B13, AP3S1 | NAAA 2745/4885DGKA 1331/4885HTR2C 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.